{{distinguish|aripiprazole|brexpiprazole}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 460112976
| IUPAC_name = 3-{2-[4-(2-methylphenyl)piperazin-1-yl]ethyl}-5,6,7,8-<br>tetrahydro-[1,2,4]triazolo[4,5-''a'']pyridine
| image = Dapiprazole.svg
<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|CDI|dapiprazole}}
| MedlinePlus = a601043
| pregnancy_category = B
| legal_status = Rx-only
| routes_of_administration = Topical ([[eye drops]])
<!--Pharmacokinetic data-->
| bioavailability = Negligible when administered topically
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| IUPHAR_ligand = 7155
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 72822-12-9
| ATC_prefix = S01
| ATC_suffix = EX02
| PubChem = 3033538
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00298
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2298190
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 5RNZ8GJO7K
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07775
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 51066
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201216
<!--Chemical data-->
| C=19 | H=27 | N=5
| molecular_weight = 325.451 g/mol
| smiles = n1nc(n2c1CCCC2)CCN4CCN(c3ccccc3C)CC4
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H27N5/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19/h2-3,6-7H,4-5,8-15H2,1H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RFWZESUMWJKKRN-UHFFFAOYSA-N
}}

'''Dapiprazole''' ('''Rev-Eyes''') is an [[alpha blocker]]. It is used to reverse [[mydriasis]] after [[eye examination]].<ref>{{cite journal |title = A Review of the Clinical Pharmacokinetics of Pilocarpine, Moxisylyte (Thymoxamine), and Dapiprazole in the Reversal of Diagnostic Pupillary Dilation |author1=Doughty, Michael J. |author2=Lyle, William M. |journal = Optometry & Vision Science |date = May 1992 |volume = 69 |issue = 5 |url = http://journals.lww.com/optvissci/Abstract/1992/05000/A_Review_of_the_Clinical_Pharmacokinetics_of.5.aspx}}</ref>

== References ==
{{Reflist|2}}

{{Antiglaucoma preparations and miotics}}
{{Adrenergics}}
{{Piperazines}}

[[Category:Alpha blockers]]
[[Category:Piperazines]]
[[Category:Triazolopyridines]]


{{antihypertensive-stub}}